Financial Architects, Inc Idera Pharmaceuticals, Inc. Call Options Transaction History
Financial Architects, Inc
- $657 Million
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IDRA
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About IDERA PHARMACEUTICALS, INC.
- Ticker IDRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,296,900
- Market Cap $188M
- Description
- Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...